| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.93B | $1.38B | $1.86B |
| YoY Revenue Growth % | +39.7% | -25.8% | — |
| Gross Profit | $955.9M | $605.1M | — |
| Gross Margin % | 49.5% | 43.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $47.6M | -$291.7M | -$659.6M |
| Operating Margin % | 2.5% | -21.1% | -35.4% |
| Net Income (GAAP) | $2.28B | -$315.5M | -$1.51B |
| EBITDA (Normalized) | $103.8M | -$271.5M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $322.9M | $273.1M | $297.3M |
| Capital Expenditures (CapEx) | $70.3M | $25.3M | — |
| Free Cash Flow (FCF) | $252.6M | $247.8M | $297.3M |
| FCF Margin % | 13.1% | 17.9% | 16.0% |
| Return on Invested Capital (ROIC %) | 0.7% | -4.3% | — |
| Cash & Short-Term Equivalents | $613.5M | $404.1M | — |
| Total Debt (Short + Long Term) | $7.26B | $9.24B | — |
| Total Stockholders' Equity | -$1.00B | -$3.46B | — |